Physician profile

James Browning III

Anesthesiology · Mobile, AL

NPI 1366416802

$367.93

in general payments reported to CMS, 2019-2025

6 companies · $198 in 2025

The $198 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).

See the full distribution for Anesthesiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$251.43

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $174.27 2020-2025 Bridion
Heron Therapeutics, INC. $120.33 2025 Zynrelef
Medtronic, INC. $23.42 2023 Kyphon Express II Kyphopak Tray
Becton, Dickinson and Company $19.97 2025 Hemosphere
Stryker Corporation $15.37 2023 Alphavent
Innovation Technologies INC $14.57 2023 Irrisept

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James Browning III

$367.93

in general payments reported 2019-2025

Years
2020-2025
Top company
Merck Sharp & Dohme LLC
Context
The $198 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).

https://glasscript.com/doctor/401739/james-browning-iii

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.